Alpha-Synuclein has emerged as a major target in Parkinson’s disease and other related conditions known as synucleinopathies.
Day: May 25, 2021
At Bachem, we believe that our employees make the difference. Representing our corporate culture of passion and commitment, they are the foundation of our success. We therefore strive to attract, retain, and develop highly motivated, well-qualified individuals.
View all jobs
Click here >>